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Red wine consumption does not affect oxidizability of low- 
density lipoproteins in volunteers1"4
Yolanda B tie Ríjke, Pierre NM Demacken Nathalie A Asseti, Lisette M Shots, Martijti B Katan» and 
Anton F>
ABSTRACT Phenolic compounds in red wine may protect 
low-density lipoprotein,s (LDL) against oxidative modification, 
thereby reducing the risk of cardiovascular morbidity. However, in 
vivo data are scarce. We gave 13 healthy volunteers 550 mL red 
wine and another 11 volunteers white wine for 4 wk in a random­
ized double-blind trial. Interference by alcoholic components of 
wine was eliminated by reducing the alcohol content to 3.5%. Red 
wine did not affect the susceptibility of LDL to C ir 1 -mediated 
oxidative modification [lag time before and after red wine drink­
ing: Cv ± SO) 61.8 ± 7.7 und 62.7 ± 11,8 min, respectively; lag 
time before and after white wine drinking: 64,5 ± 10.4 and 63.3 ±
10.8 min, respectively]. Concentrations of the antioxidants urate, 
vitamin C, and glutathione in plasma and of vitamin E and ubiqui- 
nol-10 in LDL were also unchanged after either red or white wine 
consumption. The results of this study do not show a beneficial 
effect of red wine consumption on LDL oxidation. Ant J Cl in 
Nittr 1996;63:329-34.
KEY WORDS
tion, antioxidants
Red wine, low-density lipoprotein, oxida-
INTRODUCTION
Populations with a high intake of cholesterol and saturated 
fat have a high mortality from coronary heart disease (CHD) 
(1). France is an exception, the CHD mortality is low despite a 
diet high in saturated fat (2, 3). The high consumption of 
alcohol-containing beverages, such as red wine, may, at least in 
part, explain this so-called French paradox. Alcohol consump­
tion increases plasma concentrations of high-density-lipopm- 
tein (1IDL) cholesterol (4, 5). Moderate red wine consumption 
was also found to be associated with a favorable change in 
hemostatic factors, such as blood platelet aggregation (3). The 
question is whether the supposed cardioprotective effect of red 
wine can be explained solely by the alcohol component.
In the Zutphen Elderly Study and the Seven Countries Study, 
the risk of mortality from CHD was negatively correlated with 
intake of certain flavonoids (6, 7). Flavonoids consist of two 
phcnylbenzenc (chromanol) rings linked through a pyran ring. 
They are present in fruit, vegetables, and beverages such as tea 
and wine. The most important water-soluble polyphenols with 
antioxidative capacities in red wine are the flavonols querce tin 
and myricetin, and the 3-flavanols catechin and epi(gailo)cat- 
eehin. 'These are derived from the skin of the grape and are
therefore not present in white wine, Flavonoids are mainly 
responsible for the «stringency, flavor» and color of red wine.
Frankel el al (8) reported that flavonoids extracted from 
Californian red wine protected low-density lipoprotein (LDL) 
against oxidation when added in vitro. The oxidative modifi­
cation of LDL is thought to play a key role in the development 
of early atherosclerotic lesions (9). Red wine flavonoids could
inhibit LDL oxidation (8, 10-13).
Data in vivo are contradictory. Fuhrman et al (14) found that 
LDL oxidation was inhibited in subjects who had drank red 
wine, whereas Sharpe et al (15) did not find such an effect. We 
focused on the effect of the nonalcoholic components of red 
wine by reducing the alcohol content. Thus, we assessed 
whether the consumption of low-alcohol red wine affects the 
oxidizability of LDL and the concentrations of antioxidants in
SUBJECTS AND METHODS 
Study design
This study was approved by the ethical committee of the 
Academic Hospital, University of Nijmegen, and atl subjects 
gave their informed consent before participation. Twenty-four 
healthy nonsmoking, normolipidemic volunteers (aged 22-63 
y; 19 males, 5 females) participated. Subjects were noi using 
vitamin or mineral supplements, Before study entry subjects* 
average total alcohol consumption was 0-240 g aleohol/wk.
Eleven subjects were moderate red wine drinkers (2¿l..120 g
aleohol/wk), All subjects consumed white wine lor a 2-wk 
baseline period (Figure I). They were then randomly assigned 
to consume white or red wine for another 4 wk (tesi period), 
with stratification for age, sex, and plasma cholesterol concen­
tration. The distribution of the moderate red wine drinkers into
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Medicine* University Hospital Nijmegen, The Wageningen Agricultural 
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FIGURE 1, Study design, All subjects consumed low-nlcoliol white 
wine ibi* 2 wk before being randomly assigned to consume low-alcoliol red 
or white wine lor im additional 4 wk,
the red wine and the white wine groups was .seven and four, 
respectively. Ten men and three women aged 38.2 ± 9,8 y 
I with a plasma total cholesterol concentration of 5.25 it 0,71 
mmol/L and a body mass index (in kg/nr) of 22,8 ± 2.2] 
received red wine and nine men and two women aged 36.4 ±
11.8 y (with a plasma total cholesterol concentration of 5.37 ± 
0,82 mmol/L and a body mass index, of 22.7 ± 2.1) continued
to consume white wine.
Participants consumed 550 mL wine (lour to five glasses, 
^12  g alcohol/d per person) in the evening, Wine was deliv­
ered daily to the volunteers. All subjects followed a low- 
flavonoid diet and abstained from tea and,red wine. Food 
intake was checked by 5-d written records. Intake of quercetin, 
kaempferol, myrieetin, api gen in, and luteo lift was estimated by 
using data from Hertog et al (16).
Preparation of wines
We used white wine from the Loire region in France (Baron 
Charles, 1993) and red wine from Italy (Chianti Classico, 
1991) because this red wine tends to have higher querce tin 
contents than French wines (17). Alcohol was removed by 
evaporation at 35 nC under a pressure of 2 cm Mg. Total 
volume loss was <  15%. Final alcohol concentrations (,v ± 
SEM) were 3.5 ± 0.2% for white wine and 3.4 ± 0.3% for 
red wine. The alcohol content was determined by using a 
Bochringer Mannheim test kit (no. 176290; Mannheim, Ger­
many). Nonpolyphenolic pigments (H I02, 4-(4'-su!fo-l'-phi> 
ny 1 azo)-1 -( 4 \su 11 o p h e ny 1V 5 - h y d r o x y py r a/.o 1 o n - 3 - e a r bo n i e 
acid; EIK), chinophtalon-disulfate; E122 2-(4'-sulfo-r-naph- 
tylazo>l-naphlol-4"Sulíate; E l32, indÍgotm-5'-disulfatc; and 
El 51, Brilliant Black; Jacob Hooi, Linimen, Netherlands) and 
red beet (root) juice (37.5 niL/L; Loverendale, Netherlands) 
were added to both wines to make them indistinguishable. In 
addition, the wines were coded with random codes. As a result, 
subjects were unable to distinguish white from red wine. Quer­
cetin and myrieetin concentrations were determined essentially 
as described by Hertog et al (16). Catechin, epieatechin, and 
epigalloeateehin were determined essentially as described by 
Bailey and Nursten (18). Before removal of the alcohol the red 
wine contained (wet wt) 6.2 ± 0.2 mg quere et in/kg, 3.4 ± 0.2 
mg myricetin/kg, 27 mg catechin/kg, 20 mg epieateehin/kg, 
a nd I I 6 m g ep i gal l oc atech i n/kg. The w h i le wine eon ta i ned
<  0 . 1 mg quercctin/kg, 1 * I mg myricetin/kg, and 2 mg gallate/ 
kg. The low-alcohol red wine contained 6.1 ± 0.1 mg querce- 
tin/kg, 3.3 ± 0,1 mg myricetin/kg, 12 mg eateehin/kg, 19 mg
epicatechin/kg, and 107 mg epigalloeateehin/kg. The low-al­
cohol white wine contained < 0.1 mg quercetin/kg, I mg 
myricetin/kg, and 2 mg gallate/kg.
In vitro measurement of antioxidant capacity of wine
To determine the antioxidant activity of the two wines in 
vitro, plasma (containing 1 mmol EDTA/L) from a normolipi- 
demic donor was dialyzed against two changes of I L chelex 
100-treated phosphate-buffered saline at 4°C  to remove con­
taminating transition metal ions (19). Before the incubation, 1 
mL plasma was preincubated with 10-50 ju-L white or red wine 
for 5 min at 37 °C, followed by addition of 94 mmol/L 2,2'- 
azobis( 2-ami dì nopropane) hydrochloride (AAPH) (200 /¿L 625 
mtnol AAPH/L in 0.154 mol NaCI/L) (Polyselenees, Ine, 
Warrington, FL). AAPH generates water-soluble peroxy radi­
cals at a constant rate (19). After 3 h of incubation, the
oxidation was stopped by refrigeration and the degree of li pici 
peroxidation was assessed by measuring the amount of thio- 
barbituric acid-reactive substances (TBARS), expressed as 
/xmol malondialdehyde (MDA) cquivalents/L plasma (20, a 
modification of 21).
Blood measurements
Two fasting blood samples were collected 10-12 h after 
wine consumption into evacuated lubes on separate days at the 
end of both the baseline and test periods. Blood was collected 
into tubes containing K3-EDTA (1 g/L) for cholesterol, cx- 
tocopherol, ubiquinol-10, and glutathione determinations and 
for the oxidation assay. Additive-free tubes were used for urate 
and lithium-heparin-containing tubes for vitamin C. Blood was 
placed immediately on ice and plasma was separated by cen­
trifugation at 3200 X # for 8 min at 4 °C within 1 h of 
sampling. Plasma aliquots were rapidly fro zed in nitrogen and 
stored at —80 °C after the addition of saccharose (6 g/L) to 
stabilize the lipoproteins. Butyl ated hydroxy toluene (linai, con­
centration 250 mg/L), a lipophilic antioxidant, was added to the 
plasma samples used for the measurement of a-tocopherol and 
ubiquinol-10 concentrations and TBARS.
Cholesterol concentrations were determined with an enzy­
matic method with reagent from Bochringer (CHOD-PAP re­
no. 1442350; Bochringer Mannheim Mannheim, 
Germany) on a Hitachi 747 analyzer (Bochringer Mannheim), 
HDL cholesterol was quantified in plasma after precipitation of 
LDL and very "low-density lipoprotein/i ntcrmediate-density li­
poprotein with the polyethylene glycol 6000 method (22). For 
the ox i dati on assay, the protein content of LDL was measured 
by the method of Lowry et ai (23), with chloroform extraction 
to remove turbidity, and using bovine serum albumin as a 
standard. The interassay CVs were < 2% for both cholesterol 
and triaeylglycerol determinations.
Samples of the same subjects were always analyzed in the 
same run. In each run, samples obtained from subjects who 
received red wine were analyzed together with samples ob­
tained from subjects who received white wine. Ascorbic acid 
and ubiquinoMO were analyzed within 30 min after thawing.
Determination of antioxidant concentrations
Glutathione was determined in whole blood by an enzymatic 
method according to Griffith (24). The oxidized form of glu­
tathione (GSSG) was determined within 6 h of blood sampling.
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The reduced form of glutathione (GSH) was determined within
4 wk in the acid, protein-free suponíate. Urate in serum was 
determined within 3 h with a Hitachi 747 analyzer (25), Vita­
min C (sum of i .-ascorbic and dchydro-L-ascorbie acid) in 
whole blood was determined by HPLC with fluoromctric 
detection (26).
«-Tocopherol and ubiquinoMO were determined within 2 
wk of storage by HPLC coupled to an electrochemical detector 
(Decade; Antee, Leiden, Netherlands) (27). To determine an­
tioxidant concentrations in LDL, LDL was isolated by a short- 
run nonequilibrium density-gradient ultracentrifugation 
(120 000 X for 4 h at 4 °C) using a Kontron TIT 45.6 
fixed-angle rotor (Kontron AG» Zurich, Switzerland) (28). Af­
ter isolation, LDL preparations were immediately assayed for 
antioxidants as described above. To prevent oxidation of 
ubiquinol-10, LDL was not dialyzed. The concentration was 
expressed per mmol LDL cholesterol because of potential 
contamination with trace amounts of albumin.
Oxidizability of LDLs
Oxidation experiments were performed within 2 mo of stor­
age. Plasma samples of participants were thawed rapidly and 
LDL was isolated by density ultracentrifugation (285 000 X g 
for 18 h at 4 °C) using a swingout Beckman SW40 rotor in a 
Beckman L55 ultracentrifuge (Beckman, Palo Alto, CA). To 
protect the LDL against oxidative modification during isola­
tion, 10 /xmol EDTA/L was added to each density solution. 
LDL was isolated at a density of LO 19-1.063 kg/L, LDL was 
not dialyzed. The time between isolation and the oxidation 
experiment was always <  90 min. The susceptibility of LDL to 
in vitro C i r 1 -mediated oxidation was determined as described 
by Esterbauer et al (29) as modified by Prineen et al (30), After 
isolation, LDL was diluted immediately with NaChEDTA 
(1.18 mol/L: 10 /xmol/L) to a final concentration of 114 mg 
protein/L, and sodium phosphate (pH 7.4) was added to a final 
concentration of 10 mmol/L,. Oxidation was initiated by adding 
CuSO;, to a final concentration of 38 /umol/L at 37 °C. The 
kinetics of the oxidation of LDL were determined by monitor­
ing the change of the 234-nm diene absorption in a thermostat- 
controlled ultraviolet spectrophotometer (Lambda 12; Perkin 
Elmer, Gouda, Netherlands), equipped with a nine-position 
automatic sample changer. Absorbance curves of four LDL 
preparations from one subject, two before and two after the test 
period, were analyzed in parallel. In this way small differences 
in the oxidation parameters between the LDL preparations 
isolated from the plasma before and after the test period could 
be detected. Each LDL preparation was oxidized in two oxi­
dation runs on the same day. The oxidation assay was validated 
by analyzing one reference LDL, prepared from pooled plasma 
stored at ~~80 °C, in every oxidation run. Por the reference 
LDL, the inlerassay CV for lag time, oxidation rate, and the 
total amount of conjugated dtenes formed per milligram of 
LDL protein were <  3%.
Statistical methods
For each subject the change of each variable was calculated 
as the mean of the two values obtained at the end of the lest 
period minus the mean at the end of the baseline period. 'The 
null hypothesis was that the mean of the changes in the red 
wine group equalled those in the while wine group. This
hypothesis was tested by a i test. Repeated-measures analysis 
of variance (ANOVA) was used to assess the effect of the 
baseline versus the test period and of white versus red wine. 
Where F test results were significant, the results of unequal 
variances with separate degrees of freedom were used, Where 
F test results were not significant, results from the pooled 
degrees of freedom were used. All data analyses were per­
formed by using SPSS/PC software (SPSS Inc, Chicago),
RESULTS
The daily average intake of the sum of quercetin, kaempferol, 
myrieetin, api gen in, and luteolin from food was 8.1 ± 4,6 mg in 
the white wine group and 10.0 ± 6,0 mg in the red wine group, 
The daily additional intake of quercetin plus myrieetin was 5.3 mg 
from red wine and 0.6 mg Irom white wine. Beside these two 
davonoids, high concentrations of catechin-like flavonoids are 
present, in red wine; but in this study the additional dietary intake 
of the latter could not be calculated.
Wine inhibited AAPH-indueed lipid peroxidation when 
added in vitro to plasma (Figure 2 ). At 5%, native red Chianti 
wine inhibited lipid peroxidation by 61 %, as measured with the 
TBARS assay, whereas no effect was found with white wine 
even when it was added at a final concentration of 10%. The 
low-alcohol red wine plus colorants as given to the participants 
exerted the same protective effect on plasma oxidation in vitro 
as did the native red wine. Likewise, the low-alcohol white 
wine plus added colorants failed to inhibit the AAPH-indueed 
lipid peroxidation when added to plasma in vitro (Figure 2 ).
In contrast with the in vitro findings, consumption of either 
wine for 4 wk did not affect LDL oxidizability, measured either 
as lag times, oxidation rate» or final amount of diene formation. 
Lag times, reflecting the resistance of isolated LDL against 
oxidative modification, were similar in both wine groups and 
were not prolonged after consumption of 550 mL red wine/d 
for 4 wk (Table 1). The nonsignificant differences between 
changes in the red and white wine groups were in fact in the 
opposite direction of what would be expected if red wine
'» (vjv)
KIGURK 2 . The effect of in vilrn midition of white or red wino on the 
susceptibility of plasma to lipid peroxidalion before and «fier réduction of 
the alcohol content. Plasma isolated from a normoliptdemie donor was 
ineuhated with 2,2'“a/obis(2"Umidinopi'npune)(AAPH, 100 mmol/L) in the 
presence of the indicated concentrations of either white or red wine for 3 
h at 37 "C. II, native white wine; O, nuli ve red wine; M, low* alcohol while 
wine plus colorants; • ,  low-alcohol red wine plus col tuants. Values are 
expressed as percentages of maximal lipid peroxidation tn 2 .In The 
maximal AAPíLindueed lipid peroxidation, IK.O /imol malondialdehyde 
(MDA) equivalents/!, in plasma was measured in the absence of wine.
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T A B LE ï
Oxidation kinetics of LDL isolated ÍVoiu (he plasma of subjects al ihc end of the 2-wk baseline period (white wine) and at the end 
period (red or white wine)
v:£%
White wine' Red wine' Difference
Or = I I) {n - 13) between changes*1
Lug time (min)
Baseline (white wine only) 64.5 ± 10.4 61.8 ± 7.7
Test period 63.3 ± 10.8 62.7 ±11.8 1.4 ( — 3.1, 5.9)
Oxidation rate (mmol dicnes • g LDL protein 1 • min""1
Baseline (white wine only) 14.1 ± 3.1 13.9 ± 2.1
Test period 13.3 ± 2.4 14.6 ± 2.3 1.5 (-“0.5, 3.5)
Dicnes,,,,,* (mtnol/g LDL protein)
Baseline (white wine only) 514.3 ± 18.2 525.9 ± 34.8
Test period 502.1 ±21.6 532.0 ±31.8 18.4 (0, 30,7)
' x ± SD.
.v; 95% CI in parentheses.
1 —
« J
■ J  MM— M i
protected against oxidation. In three subjects with a basal 
flavonoid intake >  15 mg, lag times after red wine consump­
tion were also not different from baseline values. The rate of 
diene formation and the maximal amount of di enes formed 
after red wine consumption were not different from baseline 
values (Table I). Antioxidant concentrations were not affected 
either; the mean value for «-tocopherol was 4.J ± LI /xmol/ 
mmol LDL cholesterol at baseline and 4,1 ± 1.1 after red wine 
drinking, and the content of ubiquinol-10 was 86 ± 51 nmol/ 
mmol LDL cholesterol and changed to 91 ± 69 (NS). The 
concentrations of aqueous and lipophilic antioxidants in plasma 
were also unchanged (Table 2) as were TBARS (baseline and 
test values: 1.08 ± 0.27 and 0.99 ± 0.13 jumol/L, respective­
ly). Total cholesterol, LDL cholesterol, HDL cholesterol, and 
total triacylglycerol concentrations in plasma did not change 
significantly in either group (Table 3),
DISCUSSION
In our double-blind study consumption of four to five glasses 
of red wine per day for 4 wk did not affect copper-mediated
LDL oxidation in healthy volunteers, «-Tocopherol and 
ubiquinoMO concentrations of LDL after red wine consump­
tion were similar to baseline values.
Interest in red wine flavonoids has been stimulated by the 
growing evidence that free radical-mediated events are in­
volved in the early formation of fatty streaks in coronary 
arteries (9). The beneficial effect of red wine consumption on 
the prevention of CHD (31) might be due to the HDL-raising 
effect of ethanol rather than of flavonoids, We therefore used 
wine from which most of the alcohol had been removed. This 
was evidently successful because no effect on plasma HDL- 
cholesterol concentrations was seen. The lack of change in 
plasma lipids also prevented compositional changes in LDL, 
which can influence LDL oxidizability (32, 33).
Our data conflict with those of Fuhrman et a! (14), who 
observed a fourfold increase in the lag phase before oxidation 
of LDL in volunteers who had consumed 500 mL red wine 
compared with white wine. The effect was seen after 2 wk of 
treatment, but no difference was seen after I wk. The extent of 
the effect that Fuhrman et al saw is surprising: high doses of 
vitamin E (30, 34-36) decreased LDL oxidizability only 1.3- to
TABUS 2
Coneentnitions of anlioxidants in plasma or blood at the end of die 2-wk baseline period (while wine) and after the 4-wk test period (red or 
while wine)
» M l M D ! IW U h
'  .V ± SI).
■’ .v; y.V/ii Cl in puiunilicscs.
White wine' 
(h 11 )
Red wine' 
(n *  13)
«-Tocopherol (/¿mol/L plasma) 
Baseline 23,5 1 ; 6.3 22.8 ± 6.6
'Pest period 23.7 ± 5.6 22.9 ± 5.0
UhiquinoMO (nmol/L plasma)
Baseline 598 :t 176 553 ± 163
'l'est period 530 ± 152 613 ± 301
Vitamin C (/imol/L blood)
Baseline 42.3 ± 8.7 48.4 ± 9.2
T’cst period 46.3 1; 9.7 48.2 ± 10.6
Total glutathione (mmol/L hlood)
Baseline 0.79 ± 0.15 0.73 ± 0.16
Test period 0.58 ± 0.15 0.63 ± 0.16
Untie (mmol/L serum)
Baseline 0.33 ± 0.07 0.33 t  0.06
7 est period „ 0.33 ± 0.07 0.33 ± 0.07
IM «* ' MMfÉIL.J 4gr4 M M 1 + ? f  t
Difference between changes**
0 (."> S ”> I \
1  M  è m  y  é m  t  %  *  %  i l /
108 (-KH, 3(B)
0.12 (-10.9.2.7)
4.12 (-0,05, 0.28)
0.01 ( ..0.03, 0.01)
f l
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TABI JC 3
Concern nil ions of total cholesterol, IIDL cholesterol, and triaey I glycerol 
in plasm« at the end of Ihe 2-wk baseline period (white wine) und after 
the 4-wk test period (red or white wine)'
White wine' 
(// ^  1 1 )
Red wine' 
{n = 13)
Dii Tere nee between 
changes**’
mmol/L
Cholesterol
Baseline 5.37 ± 0.82 5.25 £ 0.71
Test period 5.21 ± 0.75 5.13 ± 0.60 0.05 ( ..0.20, 0,30)
MDL cholesterol
Baseline 1.29 ± 0.42 1.42 :t 0.33
Test period L3I 0,38 1.49 £ 0.33 0.0ft ( 0.04, 0,1ft)
Triaeylglyeerol
Baseline Lift <; 0.44 0.98 ± 0.35
Test period 1,20 0,47 LOO ± 0.31 -0,02 ( T), 19, 0.15)
/ V, V,, O h
*  %  M I U  \  f  I  V  %
4\v; 95% CM in parentheses,
2.5-fold, ancl even long-term treatment with the most efficient 
antioxidant known, probueol (250 mg/d for 4 mo), prolonged 
the lag time by no more than threefold (37). The fourfold 
increase in lag time reported by Fuhrman et al (14) for a 
relatively modest intervention is thus unprecedented and diffi­
cult to explain.
The design of our study differed from that of Fuhrman el al 
(14) by having a baseline period of 2 wk with white wine, 
followed by a 4-wk treatment. The effect of red wine consump­
tion on LDL, oxidizability was expected to be greater after 4 
than after 2 wk. In contrast with the study of Fuhrman et al, all 
subjects followed a low-flavonoid diet during the study. There 
were also essential differences in the methods used by both 
research groups for measuring LDL oxidizability, ie, the omis­
sion of the dialysis step in our procedure to prevent early 
oxidative modification of LDL. The red Italian wine we used 
showed the same antioxidative capacity in vitro as that found 
by Fuhrman et al (14) with French wine. This antioxidative 
capacity was not influenced by reduction of the alcohol content 
or addition of pigments and beet juice used for blinding. 
Flavonoid concentrations of the red wine were similar to those 
measured in French wines (38, 39), and were not changed by 
these manipulations. In addition, flavonoid concent rati (ins in 
plasma are not influenced by storage of plasma at HO "C for 
as long as 4 mo (PC1!I Hollman, unpublished observations,
1995).
Red wine has been reported to increase the antioxidative 
capacity of plasma ( 14, 40). This effect was also ascribed to red 
wine flavonoids. Because of the close interaction between the 
hydrophilic and lipophilic antioxidant mechanisms, an increase 
in the antioxidant capacity of plasma could decrease LDL 
oxidizability in vivo and probably also in vitro. Fuhrman et al 
(14) assessed total plasma lipid peroxidation in vitro by mea­
suring TBARS after the addition of the free radical generator 
AAPH whereas we estimated potential plasma lipid peroxida­
tion by measuring a spectrum of relevant protective antioxi­
dants. It has been reported that urate, ascorbic acid, thiol 
proteins, u'-tocopherol, and bilirubin are the main contributors 
to total plasma antioxidant capacity (41 ). Our data showed that 
red or white wine did not influence the concentration of either
lipophilic or hydrophilic antioxidanls; it is there I ore not sur­
prising that LDL, oxidizability was also not influenced.
A recent study by Ruf eL al (42) in rats reported that oral 
administration of low-alcohol red wine resulted in decreased 
alcohol-induced lipid peroxidation in plasma and reduced 
platelet aggregation in vivo. Ruf et al (42) suggested that 
alcohol promotes absorption of polyphenol ics in the intestine. 
Hitherto, few data were available on the absorption and me­
tabolism of individual flavonoids after consumption. Our 
knowledge of the absorption of flavonoids from foods is lim­
ited and studies of this kind are needed. The amounts absorbed 
may be insufficiënt to exert antioxidative activity in vitro either 
in tolal plasma or in isolated LDL.
In conclusion, consumption of a fairly large dose of red wine 
did not affect in vitro LDL oxidizability in volunteers, The 
French paradox, if it exists at ail, may be due to factors other 
than the effect of wine on LDL oxidation. 0
We thank J Vogelaar and M Hectors for excellent technical assistance 
mid Peter Mollman and Lilian Tij burg lor determination of flavonoids in 
wine.
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